Download your free eBook: Enhancing clinical trial success for pro-cognitive drugs in schizophrenia

Cognitive impairment associated with schizophrenia (CIAS) has a significant impact on patient wellbeing, which has substantial costs for both the patient and society in general.

Many pharmaceutical companies have conducted pro-cognitive drug trials in an attempt to address CIAS, but none have been successful. This leads us to question whether the compounds are simply ineffective or if methodological factors may be limiting progress.

In this eBook, we discuss the challenges facing pro-cognitive trials, and what they mean for drug development programmes, covering:

  • Key barriers in pro-cognitive trial designs, and how to overcome them
  • How patient recruitment strategies can improve trial outcome
  • How to select the right outcome measures to convincingly support trial claims

Simply fill out the form to get your copy today!

Country *

We would like to keep you informed with the latest news, data and innovations from the neuroscience and clinical trial community. We'll always treat your contact information with great care and will never allow other companies to access your information for marketing purposes.

Please let us know if you would like us to contact you or not by selecting one of the options below.